U.S. IND filed for THB335 with anticipated clinical trial start during 2Q’24
Strong financial position with cash and cash equivalents totaling $269.1 million
as of December 31, 2023
Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results
THIRD HARMONIC BIO INC
NASDAQ:THRD (2/11/2025, 8:00:01 PM)
After market: 3.26 +0.01 (+0.31%)3.25
-1.4 (-30.11%)
THRD Latest News and Analysis
12 hours ago - ChartmillTuesday's session: top gainers and losersIntrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
16 hours ago - ChartmillTuesday's session: gap up and gap down stocksLet's have a look at the gap up and gap down stocks in today's session.
18 hours ago - ChartmillWhich stocks are moving before the opening bell on Tuesday?As the US market prepares to open on Tuesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
